| Authors: |
Janjuha S; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. sharan.janjuha@pharma.uzh.ch., Haenggi T; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Chamberlain TC; Acuitas Therapeutics, Vancouver, British Columbia, Canada., Rothgangl T; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Kissling L; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Wilhelm M; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Mathis N; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Boeck D; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Marquart K; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Ioannidi E; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Moon WJ; Acuitas Therapeutics, Vancouver, British Columbia, Canada., Muramatsu H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Vadovics M; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Pardi N; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Semple SC; Acuitas Therapeutics, Vancouver, British Columbia, Canada., Tam YK; Acuitas Therapeutics, Vancouver, British Columbia, Canada., Schwank G; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. schwank@pharma.uzh.ch. |
